Related Experiment Video
Updated: May 7, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
The Role of AIM2 in Cancer Development: Inflammasomes and Beyond
Lina Sui1,2, Yuling Xi1,2, Siping Zheng1,2
1Center for Immunology, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, Jiangxi 341000, China.
Abstract:
Absence in melanoma 2 (AIM2) protein functions as a double-stranded DNA sensor and is critical for host defense against intracellular bacterial and viral pathogens. Recent research has highlighted the significance of AIM2 in the pathogenesis of diverse malignancies. Through its recognition of foreign or intracellular dsDNA, AIM2 triggers inflammasome activation, resulting in the release of pro-inflammatory cytokines such as IL-1β, IL-18, and induction of pyroptosis. Additionally, AIM2 can engage alternative signaling pathways, such as AKT and NF-κB, independent of inflammasome activation, to modulate cancer progression. This review provides a comprehensive overview of recent advancements in understanding the involvement of AIM2 in the pathogenesis of different types of cancer through both inflammasome-dependent and inflammasome-independent mechanisms. Furthermore, we discuss the potential applications and challenges associated with targeting AIM2 in cancer therapy.
Insights
The Absence in Melanoma 2 (AIM2) protein senses DNA, impacting cancer. This review explores AIM2
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Absence in Melanoma 2 (AIM2) is a DNA sensor crucial for immunity.
- AIM2 plays a role in cancer development and progression.
- AIM2 activation leads to inflammasome assembly and cytokine release.
Purpose of the Study:
- To review the role of AIM2 in cancer pathogenesis.
- To discuss inflammasome-dependent and -independent mechanisms of AIM2 in cancer.
- To explore therapeutic strategies targeting AIM2 in cancer treatment.
Main Methods:
- Literature review of recent advancements in AIM2 research.
- Analysis of AIM2's dual role in innate immunity and cancer.
- Synthesis of data on AIM2's signaling pathways (inflammasome and alternative).
Main Results:
- AIM2 recognizes dsDNA, initiating immune responses and potentially driving cancer.
- AIM2 influences cancer progression via inflammasome activation (IL-1β, IL-18, pyroptosis) and alternative pathways (AKT, NF-κB).
- AIM2's multifaceted roles in cancer pathogenesis are highlighted.
Conclusions:
- AIM2 is a significant factor in diverse cancer types.
- Targeting AIM2 presents potential therapeutic opportunities.
- Challenges in AIM2-targeted cancer therapy require further investigation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Caspases
The Extrinsic Apoptotic Pathway

